SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-017417
Filing Date
2013-01-18
Accepted
2013-01-18 16:11:59
Documents
7
Period of Report
2013-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d468398d8k.htm 8-K 21149
2 UNDERWRITING AGREEMENT d468398dex11.htm EX-1.1 127068
3 OPINION OF COOLEY LLP d468398dex51.htm EX-5.1 7948
4 PRESS RELEASE DATED JANUARY 17, 2013 d468398dex991.htm EX-99.1 9078
5 PRESS RELEASE DATED JANUARY 18, 2013 d468398dex992.htm EX-99.2 9608
6 GRAPHIC g468398g01a78.jpg GRAPHIC 6389
7 GRAPHIC g468398g78g83.jpg GRAPHIC 13205
  Complete submission text file 0001193125-13-017417.txt   203251
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 13537712
SIC: 2834 Pharmaceutical Preparations